- Home
- INCR vs SRTS Comparison
INCR vs SRTS Comparison
Compare INCR & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- SRTS
- Stock Information
- Founded
- INCR 1994
- SRTS 2010
- Country
- INCR Israel
- SRTS United States
- Employees
- INCR N/A
- SRTS N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- INCR Health Care
- SRTS Health Care
- Exchange
- INCR Nasdaq
- SRTS Nasdaq
- Market Cap
- INCR 84.5M
- SRTS 75.5M
- IPO Year
- INCR N/A
- SRTS 2016
- Fundamental
- Price
- INCR $1.51
- SRTS $4.38
- Analyst Decision
- INCR
- SRTS Strong Buy
- Analyst Count
- INCR 0
- SRTS 3
- Target Price
- INCR N/A
- SRTS $11.67
- AVG Volume (30 Days)
- INCR 28.2K
- SRTS 66.9K
- Earning Date
- INCR 08-15-2025
- SRTS 08-07-2025
- Dividend Yield
- INCR N/A
- SRTS N/A
- EPS Growth
- INCR N/A
- SRTS N/A
- EPS
- INCR N/A
- SRTS 0.11
- Revenue
- INCR $65,575,323.00
- SRTS $39,488,000.00
- Revenue This Year
- INCR $69.54
- SRTS $4.33
- Revenue Next Year
- INCR $41.75
- SRTS $26.74
- P/E Ratio
- INCR N/A
- SRTS $39.16
- Revenue Growth
- INCR N/A
- SRTS 24.75
- 52 Week Low
- INCR $1.17
- SRTS $4.01
- 52 Week High
- INCR $2.62
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- INCR 46.22
- SRTS 46.37
- Support Level
- INCR $1.48
- SRTS $4.15
- Resistance Level
- INCR $1.64
- SRTS $4.44
- Average True Range (ATR)
- INCR 0.05
- SRTS 0.19
- MACD
- INCR -0.00
- SRTS -0.02
- Stochastic Oscillator
- INCR 30.81
- SRTS 40.48
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.